Enhancing Medication Safety: Reducing Administration Errors in Oncology Setting

Document Type : Research Articles

Authors

1 Pharmacy Department, National hematology and bone marrow transplant center, University Medical City , Muscat, Oman.

2 Quality and Accreditation Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.

3 Pharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.

4 Nursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.

5 Medical Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.

6 Informatics and Cybersecurity Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.

7 Center Incharge, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.

Abstract

Purpose: This project aimed to minimize medication errors and improve safe medication administration in an oncology setting in Muscat, Oman. Methods: The study, spanning from the second quarter of 2022 to the first quarter of 2023, employed a one-group pretest-posttest quasi-experimental design, assessing key performance indicators (medication error and medication administration errors rates per 1000 patient days) on quarterly basis before and after implementing targeted interventions.  Interventions focused on medication management processes and Healthcare Informatics System (HIS), Environment and equipment, and Education The project utilized the FOCUS PDCA (find, organize, clarify, understand, select, plan, do, check and act) methodology. Ethical clearance was obtained from the Institutional Review Board. Results: The results showed significant reductions were observed in both medication error and medication administration error rates following the implementation of interventions. Specifically, the medication error rate decreased from 12.59 in the Second Quarter of 2022 (pre-intervention) to 5.26 in the Fourth Quarter of 2023 (post-intervention), with an overall ANOVA F-value of 9.2950 (p = 0.035). Similarly, the medication administration error rate declined from 5.39 to 1.29 over the same period, resulting in an ANOVA F-value of 8.2320 (p = 0.044). Conclusion: The study indicates a significant improvement in patient safety outcomes following the intervention implementation, underscoring the effectiveness of the interventions in reducing medication errors and administration errors.

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention
Volume 26, Issue 1
January 2025
Pages 269-277

Files

History

  • Receive Date: 16 September 2024
  • Revise Date: 07 November 2024
  • Accept Date: 23 January 2025

Share

How to cite

Statistics